Our genes contribute anything from 15 to 95% of how we react to medicines. Why is this the case, and when is genetic testing necessary to avoid the risk of potential side effects?

In focus / 21 August 2024

Medication errors account for the bulk of adverse events to medicines. How do they occur, how do we ensure they are reported if they do occur, and how may we prevent them?

In focus / 07 June 2024

Medication errors significantly contribute to the global number of ADRs per year. How may we best prepare the pharmacovigilance community to tackle the problem?

In focus / 02 April 2024

The introduction of new medications for HIV and TB in Namibia required a more proactive hand in monitoring their safety. For the Namibian TWG, active surveillance was the answer.

In focus / 23 October 2023